Highlights NanJing Pharmaceutical Company Limited

Equities

600713

CNE000000KV1

End-of-day quote Shanghai S.E. Other stock markets 06:00:00 2024-05-15 pm EDT			5-day change	1st Jan Change
4.88 ^CNY	-1.01%		-1.01%	+0.83%

Apr. 29	NanJing Pharmaceutical Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Apr. 08	NanJing Medical Plans to Issue Up to 6 Billion Yuan in Ultra Short-Term Bonds	MT

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

NanJing Pharmaceutical Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 29	CI
NanJing Pharmaceutical Company Limited Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 06	CI
NanJing Pharmaceutical Company Limited Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-30	CI
NanJing Pharmaceutical Company Limited Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-30	CI
NanJing Pharmaceutical Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-28	CI
NanJing Pharmaceutical Company Limited Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-30	CI
NanJing Pharmaceutical Company Limited entered into Framework Agreement to acquire 55% stake in Suzhou Tianqing Xingwei Pharmaceutical Co., Ltd., a 55% stake in Zhejiang Tianqing Zhongwei Pharmaceutical Co., Ltd., and a 100% of Lianyungang Chia Tai-Tianqing Pharmaceutical Co., Ltd.	22-12-20	CI
NanJing Pharmaceutical Company Limited Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-28	CI
NanJing Pharmaceutical Company Limited Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-23	CI
NanJing Pharmaceutical Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2022	22-04-29	CI
NanJing Pharmaceutical Company Limited Reports Earnings Results for the Full Year Ended December 31, 2021	22-03-25	CI
NanJing Medical’s Controlling Shareholder Boosts Stake to 44.2% For $158 Million	22-02-21	MT
Sichuan Luyan Pharmaceutical Co., Ltd. agreed to acquire Sichuan Yatong Pharmaceutical Co., Ltd. from NanJing Pharmaceutical Company Limited for CNY 19.9 million.	21-11-08	CI
NanJing Pharmaceutical Company Limited Reports Earnings Results for the Nine Months Ended September 30, 2021	21-10-29	CI
Nanjing Pharmaceutical Company Limited Reports Earnings Results for the Half Year Ended June 30, 2021	21-08-20	CI
Nanjing Pharmaceutical Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2021	21-04-27	CI
Nanjing Pharmaceutical Company Limited Reports Earnings Results for the Full Year Ended December 31, 2020	21-03-26	CI
Nanjing Pharmaceutical Company Limited Reports Earnings Results for the Half Year Ended June 30, 2020	20-08-21	CI
NanJing Pharmaceutical Company Limited Declares Distribution for 2019, Payable on June 24, 2020	20-06-15	CI
Nanjing Pharmaceutical Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2020	20-04-29	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights NanJing Pharmaceutical Company Limited

Equities

600713

CNE000000KV1

Highlights

Filters